SIGNES JORDEMODER- OG SCANNINGSKLINIK ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.9% 5.7% 3.6% 2.7% 2.7%  
Credit score (0-100)  36 40 50 60 59  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,969 2,184 2,587 2,582 2,060  
EBITDA  29.6 93.6 502 401 264  
EBIT  2.2 66.1 438 323 189  
Pre-tax profit (PTP)  1.1 62.4 432.6 322.4 188.3  
Net earnings  -1.5 47.0 335.9 256.4 161.4  
Pre-tax profit without non-rec. items  1.1 62.4 433 322 188  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  87.4 59.9 745 667 592  
Shareholders equity total  112 104 389 531 575  
Interest-bearing liabilities  0.0 0.0 0.0 5.0 4.7  
Balance sheet total (assets)  613 741 974 934 883  

Net Debt  -390 -572 -46.7 -137 -168  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,969 2,184 2,587 2,582 2,060  
Gross profit growth  21.0% 10.9% 18.5% -0.2% -20.2%  
Employees  3 4 4 3 3  
Employee growth %  0.0% 33.3% 0.0% -25.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  613 741 974 934 883  
Balance sheet change%  61.8% 21.0% 31.4% -4.1% -5.4%  
Added value  29.6 93.6 502.5 388.2 263.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -55 -55 620 -156 -150  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.1% 3.0% 16.9% 12.5% 9.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.4% 9.8% 51.0% 33.9% 20.8%  
ROI %  1.4% 49.7% 166.0% 64.3% 31.2%  
ROE %  -1.1% 43.6% 136.2% 55.7% 29.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  18.3% 14.0% 40.0% 56.9% 65.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -1,315.8% -611.0% -9.3% -34.2% -63.8%  
Gearing %  0.0% 0.0% 0.0% 0.9% 0.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 33.8% 9.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.0 0.9 0.3 0.5 0.8  
Current Ratio  1.0 0.9 0.3 0.5 0.8  
Cash and cash equivalent  389.9 571.8 46.7 142.2 172.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -9.5 -37.1 -407.6 -179.2 -63.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  10 23 126 129 88  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  10 23 126 134 88  
EBIT / employee  1 17 109 108 63  
Net earnings / employee  -1 12 84 85 54